journal article·2026

Preliminary study on targeted nanoparticles co-loaded with piperine and paclitaxel prodrug for ovarian cancer treatment

Shengjie Wang, Ying Liao, Bowen Yang, Lin Li, Mingrong Xi

Journal of Materials Chemistry B· Volume 14· Issue 18
Publisher page

Abstract

Combination chemotherapy incorporating natural products has emerged as an effective strategy to enhance anticancer efficacy while reducing systemic toxicity. Based on this, our study report a targeted, stimuli-responsive nanoparticle system for the co-delivery of paclitaxel (PTX) and piperine (PIP) to achieve synergistic ovarian cancer therapy. PTX was chemically conjugated to polyamidoamine (PAMAM) dendrimers via a glutathione (GSH)-sensitive disulfide linkage, while PIP was physically encapsulated within the hydrophobic core of PAMAM. Hyaluronic acid (HA) was subsequently electrostatically assembled onto the nanoparticle surface to enable CD44-mediated tumor targeting. The resulting nanoparticles exhibited a uniform spherical morphology with an average diameter of approximately 145 nm and demonstrated dual responsiveness to elevated GSH and acidic pH conditions characteristic of the tumor microenvironments. In vitro and in vivo antitumor studies revealed that the co-delivery system significantly enhanced cytotoxicity and apoptosis through synergistic PTX/PIP activity compared with monotherapy. In addition, HA modification markedly improved cellular uptake and tumor accumulation, leading to effective tumor growth inhibition in vivo with reduced systemic toxicity. In conclusion, this study highlights a rationally engineered nanocarrier integrating active targeting and stimuli-responsive release, offering a promising materials-based strategy for synergistic ovarian cancer therapy.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Piperaceae Chemical and Biological Studies · Cancer Mechanisms and Therapy · Bioactive Compounds and Antitumor Agents

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, Chengdu 610041, China

Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, China

Department of Pharmacy, The First People's Hospital of Pingdingshan, Pingdingshan 467000, China

Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu 610041, China

Funding

National Natural Science Foundation of China · Chengdu Municipal Science and Technology Program · Science and Technology Department of Sichuan Province

References (34)

Show source-provided references
1. Nayana · J. Biomol. Struct. Dyn. · 2023 · 5 · 1
2. Kahn · Gynecol. Oncol. · 2023 · 169 · 8510.1016/j.ygyno.2022.11.030 ↗
3. Liang · J. Controlled Release · 2021 · 336 · 39610.1016/j.jconrel.2021.06.034 ↗
4. Bishayee · Semin. Cancer Biol. · 2016 · 40-41 · 110.1016/j.semcancer.2016.08.006 ↗
5. Gao · Adv. Drug Delivery Rev. · 2022 · 188 · 11444510.1016/j.addr.2022.114445 ↗
6. Tincu · Pharmaceutics · 2023 · 15 · 112510.3390/pharmaceutics15041125 ↗
7. Mitra · Front. Pharmacol. · 2021 · 12 · 77241810.3389/fphar.2021.772418 ↗
8. Wojtowicz · Int. J. Mol. Sci. · 2021 · 22 · 424310.3390/ijms22084243 ↗
9. Kazmi · Polymers · 2022 · 14 · 134910.3390/polym14071349 ↗
10. Babadi · Int. J. Pharm. · 2022 · 624 · 12199010.1016/j.ijpharm.2022.121990 ↗
11. Quijia · J. Mol. Struct. · 2024 · 1305 · 13780110.1016/j.molstruc.2024.137801 ↗
12. Abolhassani · J. Drug Delivery Sci. Technol. · 2024 · 92 · 10534610.1016/j.jddst.2024.105346 ↗
13. Shehata · Int. J. Pharm. · 2022 · 619 · 12171210.1016/j.ijpharm.2022.121712 ↗
14. Tiwari · Bioorg. Chem. · 2021 · 110 · 10477610.1016/j.bioorg.2021.104776 ↗
15. Zhu · J. Nat. Prod. · 2020 · 83 · 304110.1021/acs.jnatprod.0c00599 ↗
16. AbouAitah · Pharmaceutics · 2020 · 12 · 7010.3390/pharmaceutics12010070 ↗
17. Slika · Mater. Sci. Eng., C · 2020 · 109 · 11055010.1016/j.msec.2019.110550 ↗
18. Srivastava · Phytomedicine · 2021 · 84 · 15348410.1016/j.phymed.2021.153484 ↗
19. Guo · J. Cell. Mol. Med. · 2021 · 25 · 951310.1111/jcmm.16891 ↗
20. El-Zahaby · Int. J. Pharm. · 2024 · 650 · 12373010.1016/j.ijpharm.2023.123730 ↗
21. Morsy · Eur. J. Pharm. Sci. · 2018 · 112 · 8710.1016/j.ejps.2017.11.010 ↗
22. Pal · Eur. J. Pharmacol. · 2016 · 791 · 75110.1016/j.ejphar.2016.10.019 ↗
23. Wang · Nano Lett. · 2017 · 17 · 542910.1021/acs.nanolett.7b02031 ↗
24. Wei · ACS Nano · 2023 · 17 · 2322310.1021/acsnano.3c06019 ↗
25. Wen · Chem. Commun. · 2011 · 47 · 355010.1039/c0cc04983b ↗
26. Kuppusamy · Cancer Res. · 2002 · 62 · 307
27. Song · Coord. Chem. Rev. · 2020 · 421 · 21346310.1016/j.ccr.2020.213463 ↗
28. Yang · Colloids Surf., B · 2019 · 175 · 12610.1016/j.colsurfb.2018.11.086 ↗
29. Kim · ACS Nano · 2024 · 18 · 797210.1021/acsnano.3c10732 ↗
30. Ghalehkhondabi · Int. J. Biol. Macromol. · 2024 · 263 · 13016810.1016/j.ijbiomac.2024.130168 ↗
31. Li · J. Drug Delivery Sci. Technol. · 2024 · 92 · 10534410.1016/j.jddst.2024.105344 ↗
32. Hu · Chin. Chem. Lett. · 2023 · 34 · 10859210.1016/j.cclet.2023.108592 ↗
33. Xiao · AAPS PharmSciTech · 2018 · 19 · 239510.1208/s12249-018-1070-8 ↗
34. Bera · J. Mater. Chem. A · 2015 · 3 · 8548